@article{article, title  = {{Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT‐1 and ‐2 studies outcomes from the DEPICT‐1 and ‐2 studies}},

 publisher = {{Wiley}},

 url = {{http://eprints.whiterose.ac.uk/169674/ }},

 year = {{2021}},

 month = {{2}},

 author = {{Phillip M and Mathieu C and Lind M and Araki E and Bartolo P and Bergenstal R and Heller S and Hansen L and Scheerer MF and Thoren F and Arya N et al}},

 doi = {{10.1111/dom.14248}},

 volume = {{23}},

 journal = {{Diabetes, Obesity and Metabolism}},

 issue = {{2}},

 pages = {{549-560}},

 note = {{Accessed on 2024/10/22}}}